• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, November 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Adults with disabilities screened less often for colorectal cancer

Bioengineer by Bioengineer
March 29, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Justin Kelley/MU Health

COLUMBIA, Mo. (March 29, 2017) — Colorectal cancer is the fourth most common type of cancer in the United States, with nearly 135,000 cases reported in 2016. The likelihood of surviving colorectal cancer is strongly related to the stage in which it is diagnosed. Researchers from the University of Missouri School of Medicine looked at screening adherence rates and found that individuals with certain disabilities are less likely to receive recommended preventive screenings. The researchers hope the finding will lead to targeted interventions and increased awareness for these individuals.

"Colorectal cancer is the second leading cause of cancer deaths in the U.S.," said Chelsea Deroche, Ph.D., assistant professor of biostatistics in the MU Department of Health Management and Informatics and in the Biostatistics and Research Design Unit. "However, almost 60 percent of these deaths could be prevented if people ages 50 years or older received routine screenings. When studying adherence rates to recommended screenings, we found that individuals with blindness or low vision, an intellectual disability or a spinal cord injury are less likely to receive screenings than those without these disabilities."

The U.S. Preventive Services Task Force currently recommends that individuals ages 50 to 75 be screened by one of the following methods:

  • fecal occult blood test every year;
  • sigmoidoscopy every five years, plus a fecal occult blood test every three years; or
  • colonoscopy every 10 years.

In their observational study, researchers reviewed data from South Carolina Medicaid and Medicare claims, state health plan claims and hospital discharge data between 2000 and 2009. The researchers compared colorectal screening adherence rates of individuals with either blindness or low vision, an intellectual disability or a spinal cord injury to the general U.S. population.

About 48 percent of the general population reported receiving routine screenings, compared to 34 percent of individuals with an intellectual disability, 44 percent of individuals with spinal cord injuries and 46 percent of individuals with blindness or low vision.

"These individuals may not be routinely screened for colorectal cancer due to a lack of education and awareness, transportation challenges or other barriers," Deroche said. "These findings support the need for increased awareness and targeted advocacy outreach efforts to both physicians and caregivers to ensure all individuals are screened appropriately."

###

The study, "Colorectal Cancer Screening Adherence in Selected Disabilities Over 10 Years," recently was published online in the American Journal of Preventive Medicine. Research reported in this publication was supported by the Centers for Disease Control and Prevention (U01 RFA-DD-12-006). The researchers have no conflicts of interest to declare related to this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agency.

About the MU School of Medicine

The MU School of Medicine has improved health, education and research in Missouri and beyond for more than 165 years. MU physicians treat patients from every county in the state, and more Missouri physicians received their medical degrees from MU than from any other university. For more information, visit http://medicine.missouri.edu/.

Media Contact

Derek Thompson
[email protected]
573-882-3323
@mizzounews

http://www.missouri.edu

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

Insights on Eosinophilic Granulomatosis with Polyangiitis: A Podcast

November 1, 2025
blank

Boosting Lettuce Yields with Steel Slag Compost Teas

November 1, 2025

Comparing Immune Responses: Rituximab vs. Obinutuzumab in Follicular Lymphoma

November 1, 2025

β-Hydroxybutyrate Protects Against Early Diabetic Kidney Disease

November 1, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1295 shares
    Share 517 Tweet 323
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    312 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    203 shares
    Share 81 Tweet 51
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    137 shares
    Share 55 Tweet 34

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Insights on Eosinophilic Granulomatosis with Polyangiitis: A Podcast

Boosting Lettuce Yields with Steel Slag Compost Teas

Comparing Immune Responses: Rituximab vs. Obinutuzumab in Follicular Lymphoma

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.